general Archived signal Translated · Español · 2–5m lag

El grupo de liga KiOmed Pharma abre el mercado de la medicina estética

La rama del grupo farmacéutico KitoZyme, pilotada por François Blondel, ofrece una segunda pastilla de crecimiento después de la cual se dedica al tratamiento de la artrosis genética. ...

Reported by La Libre Belgique
Read the complete report at La Libre Belgique
Verification notice

IntelMap indexes open-source reporting. This page identifies what a source reported; it does not independently confirm the claim.

INCIDENT FUSION

2 reports · 2 sources

La Libre BelgiqueEl grupo de liga KiOmed Pharma abre el mercado de la medicina estéticaLa Libre BelgiqueEl grupo de liga KiOmed Pharma abre el mercado de la medicina estética
INCIDENT EVOLUTION

10 recorded states

Signal first indexedP1 · 68% quality · 1 source

Corroboration 1→2 sources · quality 68→72P1 · 72% quality · 2 sources

Quality 72→76P1 · 76% quality · 2 sources

Quality 76→80P1 · 80% quality · 2 sources

Quality 80→84P1 · 84% quality · 2 sources

Quality 84→88P1 · 88% quality · 2 sources

Quality 88→92P1 · 92% quality · 2 sources

Quality 92→96P1 · 96% quality · 2 sources

Quality 96→99P1 · 99% quality · 2 sources

Headline updatedP1 · 99% quality · 2 sources

Explore this day in the archive →
QUALITY CONTROL

Report this signal

Reports are anonymous and retained privately for editorial review.